SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Fundamental Analysis
FRA:1SXP - Deutsche Boerse Ag - DE000A3ENQ51 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to 1SXP. 1SXP was compared to 18 industry peers in the Life Sciences Tools & Services industry. 1SXP scores excellent on profitability, but there are some minor concerns on its financial health. 1SXP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
1SXP had positive earnings in the past year.
In the past year 1SXP had a positive cash flow from operations.
1SXP had positive earnings in each of the past 5 years.
In the past 5 years 1SXP always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 9.93%, 1SXP belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
1SXP's Return On Equity of 17.64% is amongst the best of the industry. 1SXP outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 14.25%, 1SXP belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
1SXP had an Average Return On Invested Capital over the past 3 years of 15.68%. This is significantly above the industry average of 6.95%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.93% | ||
| ROE | 17.64% | ||
| ROIC | 14.25% |
ROA(3y)11.06%
ROA(5y)11.96%
ROE(3y)19.55%
ROE(5y)21.48%
ROIC(3y)15.68%
ROIC(5y)17.03%
1.3 Margins
With an excellent Profit Margin value of 15.17%, 1SXP belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Profit Margin of 1SXP has remained more or less at the same level.
The Operating Margin of 1SXP (18.95%) is better than 77.78% of its industry peers.
1SXP's Operating Margin has improved in the last couple of years.
1SXP has a Gross Margin of 32.90%. This is in the lower half of the industry: 1SXP underperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of 1SXP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.95% | ||
| PM (TTM) | 15.17% | ||
| GM | 32.9% |
OM growth 3Y3.98%
OM growth 5YN/A
PM growth 3Y0.22%
PM growth 5YN/A
GM growth 3Y-1.12%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1SXP is creating value.
Compared to 1 year ago, 1SXP has about the same amount of shares outstanding.
Compared to 1 year ago, 1SXP has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of 1SXP is 1.33, which is an excellent value as it means it would take 1SXP, only 1.33 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1SXP (1.33) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that 1SXP is not too dependend on debt financing.
1SXP has a Debt to Equity ratio of 0.10. This is amongst the best in the industry. 1SXP outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.33 | ||
| Altman-Z | N/A |
ROIC/WACC1.97
WACC7.23%
2.3 Liquidity
1SXP has a Current Ratio of 1.43. This is a normal value and indicates that 1SXP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.43, 1SXP is in line with its industry, outperforming 44.44% of the companies in the same industry.
A Quick Ratio of 1.07 indicates that 1SXP should not have too much problems paying its short term obligations.
1SXP has a Quick ratio of 1.07. This is in the lower half of the industry: 1SXP underperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
1SXP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.93%.
1SXP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.04% yearly.
The Revenue for 1SXP has decreased by -28.74% in the past year. This is quite bad
1SXP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.84% yearly.
EPS 1Y (TTM)-32.93%
EPS 3Y14.04%
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)-28.74%
Revenue growth 3Y13.84%
Revenue growth 5YN/A
Sales Q2Q%7.95%
3.2 Future
Based on estimates for the next years, 1SXP will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.91% on average per year.
The Revenue is expected to grow by 9.19% on average over the next years. This is quite good.
EPS Next Y4.94%
EPS Next 2Y12.5%
EPS Next 3Y13.4%
EPS Next 5Y12.91%
Revenue Next Year4.64%
Revenue Next 2Y7.46%
Revenue Next 3Y8.59%
Revenue Next 5Y9.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.10, the valuation of 1SXP can be described as expensive.
61.11% of the companies in the same industry are more expensive than 1SXP, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.54, 1SXP is valued at the same level.
The Price/Forward Earnings ratio is 19.63, which indicates a rather expensive current valuation of 1SXP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SXP indicates a somewhat cheap valuation: 1SXP is cheaper than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.28. 1SXP is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.1 | ||
| Fwd PE | 19.63 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SXP indicates a somewhat cheap valuation: 1SXP is cheaper than 66.67% of the companies listed in the same industry.
66.67% of the companies in the same industry are cheaper than 1SXP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.54 | ||
| EV/EBITDA | 14.05 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of 1SXP may justify a higher PE ratio.
A more expensive valuation may be justified as 1SXP's earnings are expected to grow with 13.40% in the coming years.
PEG (NY)5.08
PEG (5Y)N/A
EPS Next 2Y12.5%
EPS Next 3Y13.4%
5. Dividend
5.1 Amount
1SXP has a yearly dividend return of 0.67%, which is pretty low.
Compared to an average industry Dividend Yield of 0.73, 1SXP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, 1SXP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.67% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
16.33% of the earnings are spent on dividend by 1SXP. This is a low number and sustainable payout ratio.
DP16.33%
EPS Next 2Y12.5%
EPS Next 3Y13.4%
FRA:1SXP (8/7/2025, 7:00:00 PM)
24.6
+1 (+4.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners19.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.71B
Analysts76.84
Price Target30.48 (23.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.67% |
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP16.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.47%
Min EPS beat(2)-14.42%
Max EPS beat(2)5.48%
EPS beat(4)2
Avg EPS beat(4)7.72%
Min EPS beat(4)-14.42%
Max EPS beat(4)50.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)1.75%
Revenue beat(4)2
Avg Revenue beat(4)1.13%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)11.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)5.19%
EPS NQ rev (1m)3.21%
EPS NQ rev (3m)-0.16%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.2%
Revenue NQ rev (3m)-3.51%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.1 | ||
| Fwd PE | 19.63 | ||
| P/S | 3.81 | ||
| P/FCF | 55.54 | ||
| P/OCF | 17.96 | ||
| P/B | 4.43 | ||
| P/tB | 4.6 | ||
| EV/EBITDA | 14.05 |
EPS(TTM)0.98
EY3.98%
EPS(NY)1.25
Fwd EY5.09%
FCF(TTM)0.44
FCFY1.8%
OCF(TTM)1.37
OCFY5.57%
SpS6.46
BVpS5.56
TBVpS5.35
PEG (NY)5.08
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.93% | ||
| ROE | 17.64% | ||
| ROCE | 17.43% | ||
| ROIC | 14.25% | ||
| ROICexc | 14.71% | ||
| ROICexgc | 15.16% | ||
| OM | 18.95% | ||
| PM (TTM) | 15.17% | ||
| GM | 32.9% | ||
| FCFM | 6.86% |
ROA(3y)11.06%
ROA(5y)11.96%
ROE(3y)19.55%
ROE(5y)21.48%
ROIC(3y)15.68%
ROIC(5y)17.03%
ROICexc(3y)16.18%
ROICexc(5y)17.77%
ROICexgc(3y)16.78%
ROICexgc(5y)18.78%
ROCE(3y)19.2%
ROCE(5y)20.87%
ROICexcg growth 3Y-8.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-7.46%
ROICexc growth 5YN/A
OM growth 3Y3.98%
OM growth 5YN/A
PM growth 3Y0.22%
PM growth 5YN/A
GM growth 3Y-1.12%
GM growth 5YN/A
F-Score4
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 1.33 | ||
| Debt/EBITDA | 0.32 | ||
| Cap/Depr | 193.54% | ||
| Cap/Sales | 14.35% | ||
| Interest Coverage | 12.84 | ||
| Cash Conversion | 80.44% | ||
| Profit Quality | 45.2% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | N/A |
F-Score4
WACC7.23%
ROIC/WACC1.97
Cap/Depr(3y)291.84%
Cap/Depr(5y)279.9%
Cap/Sales(3y)17.77%
Cap/Sales(5y)16.62%
Profit Quality(3y)26.98%
Profit Quality(5y)27.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-32.93%
EPS 3Y14.04%
EPS 5YN/A
EPS Q2Q%52.94%
EPS Next Y4.94%
EPS Next 2Y12.5%
EPS Next 3Y13.4%
EPS Next 5Y12.91%
Revenue 1Y (TTM)-28.74%
Revenue growth 3Y13.84%
Revenue growth 5YN/A
Sales Q2Q%7.95%
Revenue Next Year4.64%
Revenue Next 2Y7.46%
Revenue Next 3Y8.59%
Revenue Next 5Y9.19%
EBIT growth 1Y-27.36%
EBIT growth 3Y18.37%
EBIT growth 5YN/A
EBIT Next Year39.55%
EBIT Next 3Y25.42%
EBIT Next 5Y19.41%
FCF growth 1Y1205.97%
FCF growth 3Y33.55%
FCF growth 5YN/A
OCF growth 1Y24.04%
OCF growth 3Y19.45%
OCF growth 5YN/A